REG1 Anticoagulation System: Phase IIa data

Data from the open-label, unfractionated heparin (UFH)-controlled Phase IIa Reversal-PCI trial in 26 ACS patients undergoing percutaneous coronary intervention (PCI) showed that REG1 demonstrated effe...